Plain-English translation of NCT07392450 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can help people recover better after an acute ischemic stroke—the kind caused by a blood clot blocking blood flow to the brain. Participants will receive either the medication or a placebo (a dummy treatment with no medicine) as a single infusion, and researchers will watch how safe it is and whether it helps reduce stroke damage and improve everyday abilities.
Acute ischemic stroke is a medical emergency where restoring blood flow to the brain quickly is crucial to prevent long-term damage. This trial exists to see whether this new treatment could give patients an additional tool to improve recovery and reduce the serious effects of stroke.
You likely qualify if…
You likely don't qualify if…
You will receive a single intravenous infusion (through an IV) of either the medication or placebo on your first day. Everyone also receives standard stroke hospital treatment. After that, you'll have follow-up visits and monitoring for about 3 months to track how you're recovering, check for any side effects, and see how well the treatment is working compared to placebo.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States